Armata Pharmaceuticals, Inc. (ARMP) Misses Q1 EPS by 52c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q1 EPS of ($0.69), $0.52 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $970 thousand versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
• Stifel Canada Starts BlackBerry (BB) at Buy